Dual pharmacological targeting of Mycobacterium tuberculosis (Mtb) PKNA/PKNB: A novel approach for the selective treatment of TB illness

The key players in the arsenal of combating TB; reviewing the lead InhA inhibitors

DESIGN AND SYNTHESIS OF NEW HETEROCYCLIC COMPOUNDS TO OVERCOME MICROBIAL RESISTANCE

Insights into Novel Drugs Targeting Bcl-2 protein as Potential Anti-cancer Agents

Geometrical and Topological Descriptors for Activities Modeling of some Potent Inhibitors against Mycobacterium Tuberculosis: A Genetic Functional Approach

Discovery of Novel N-Acetylpyrazolines as Microtubule Inhibitors: Design, Synthesis, Anticancer Evaluation, and Molecular Docking Study

Design, Synthesis and Antibacterial Study of New Agents Having 4-Thiazolidinone Pharmacophore

RECENT ADVANCES IN DRUGS TARGETING PROTEIN KINASES FOR CANCER THERAPY.

Design, Synthesis and Microbiological Evaluation of Novel Compounds as Potential Staphylococcus aureus Phenylalanine tRNA Synthetase Inhibitors

DESIGN AND SYNTHESIS OF NOVEL TERREMIDE AND SULFONAIDES DERIVATIVES FOR PHARMACOLOGICAL EVALUATION